TD Asset Management »

Denali Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 91k 21.46
2023-09-30 $2.8M 135k 20.63
2023-06-30 $2.5M 84k 29.51
2023-03-31 $2.0M 88k 23.04
2022-12-31 $2.8M 99k 27.81
2022-09-30 $2.8M 94k 29.29
2022-06-30 $3.6M 121k 29.43
2022-03-31 $4.3M 133k 32.17
2021-12-31 $5.5M 122k 44.60
2021-09-30 $6.4M 127k 50.45
2021-06-30 $6.5M 127k 51.03
2021-03-31 $8.0M 141k 57.10
2020-12-31 $11M 134k 83.76
2020-09-30 $3.5M 99k 35.83
2020-06-30 $1.4M 58k 24.18
2020-03-31 $573k 33k 17.52
2019-12-31 $418k 24k 17.42
2019-09-30 $368k 24k 15.33
2019-06-30 $509k 25k 20.78
2019-03-31 $543k 23k 23.21
2018-12-31 $473k 23k 20.66
2018-09-30 $487k 22k 21.74
2018-06-30 $250k 16k 15.24
2018-03-31 $323k 16k 19.70